Can Ascitic Tap Be Performed in Peritoneal Carcinomatosis?
Yes, paracentesis can and should be performed in patients with peritoneal carcinomatosis—it is both safe and diagnostically essential, with ascitic fluid cytology being positive in approximately 97% of cases when peritoneal carcinomatosis is present. 1
Safety Profile
Paracentesis is remarkably safe even in patients with malignancy-related ascites:
- Complications occur in only ~1% of patients (primarily abdominal wall hematomas), with serious complications like bowel perforation or hemoperitoneum being exceedingly rare (<1/1000 procedures) 2, 3
- Coagulopathy is NOT a contraindication unless there is clinically evident fibrinolysis or disseminated intravascular coagulation (which occurs in <1/1000 cases) 2, 1
- Routine prophylactic transfusion of fresh frozen plasma or platelets is not recommended before paracentesis, even with abnormal coagulation parameters 2, 3, 1
A critical caveat: While the guidelines focus on cirrhotic ascites, one palliative care study of cancer-related ascites documented a fatal bowel perforation among 111 patients, though most harms were mild 4. This underscores the need for careful technique but does not contraindicate the procedure.
Diagnostic Utility in Peritoneal Carcinomatosis
Ascitic fluid cytology is the gold standard for diagnosing peritoneal carcinomatosis:
- Sensitivity of 96.7% when three samples are sent, with the first sample positive in 82.8% of cases 1
- For optimal yield, send 50 mL of fresh warm ascitic fluid hand-carried to the laboratory for immediate processing 1
- Patients with peritoneal carcinomatosis typically have a serum-ascites albumin gradient (SAAG) <1.1 g/dL and high ascitic fluid protein concentration 1, 5
When to Perform Paracentesis
Diagnostic paracentesis should be performed in:
- All patients with new-onset ascites to determine etiology 2, 1, 6, 7
- When malignancy is suspected clinically, particularly with history of breast, colon, gastric, or pancreatic cancer 1
- Hospitalized patients with ascites to exclude spontaneous bacterial peritonitis 6, 7
Essential Testing for Suspected Peritoneal Carcinomatosis
When peritoneal carcinomatosis is suspected, order:
- Cell count and differential (to exclude infection)
- SAAG (will be <1.1 g/dL in peritoneal carcinomatosis without massive liver metastases)
- Total protein (typically elevated >2.5 g/dL)
- Cytology (diagnostic in 97% when properly processed) 1, 7
- Culture in blood culture bottles if infection is a concern 7
Technical Considerations
Preferred site: Left lower quadrant, 2 finger breadths (3 cm) cephalad and 2 finger breadths medial to the anterior superior iliac spine—this location has thinner abdominal wall and larger fluid pool 1
Avoid: Inferior/superior epigastric arteries (run from mid-inguinal point cephalad in rectus sheath), visible collaterals, enlarged organs 1
Special Scenarios
If cytology is negative but clinical suspicion remains high:
- Consider EUS-guided random omental FNA, which has shown 80% diagnostic yield even without visible deposits 8
- Laparoscopy with peritoneal biopsy may be needed for definitive diagnosis 1
Mixed ascites (peritoneal carcinomatosis + cirrhosis):
- These patients will have SAAG ≥1.1 g/dL (from portal hypertension) but positive cytology (from carcinomatosis) 1, 5
- Approximately 5% of ascites patients have two or more causes 1
Therapeutic Paracentesis
For symptomatic relief in malignant ascites, large-volume paracentesis is safe and effective 4, 9: